The analgesic effects of insulin and its disorders in streptozotocin-induced short-term diabetes

Physiol Rep. 2024 Apr;12(8):e16009. doi: 10.14814/phy2.16009.

Abstract

Evidence suggests that insulin resistance plays an important role in developing diabetes complications. The association between insulin resistance and pain perception is less well understood. This study aimed to investigate the effects of peripheral insulin deficiency on pain pathways in the brain. Diabetes was induced in 60 male rats with streptozotocin (STZ). Insulin was injected into the left ventricle of the brain by intracerebroventricular (ICV) injection, then pain was induced by subcutaneous injection of 2.5% formalin. Samples were collected at 4 weeks after STZ injection. Dopamine (DA), serotonin, reactive oxygen species (ROS), and mitochondrial glutathione (mGSH) were measured by ELISA, and gene factors were assessed by RT-qPCR. In diabetic rats, the levels of DA, serotonin, and mGSH decreased in the nuclei of the thalamus, raphe magnus, and periaqueductal gray, and the levels of ROS increased. In addition, the levels of expression of the neuron-specific enolase and receptor for advanced glycation end genes increased, but the expression of glial fibrillary acidic protein expression was reduced. These results support the findings that insulin has an analgesic effect in non-diabetic rats, as demonstrated by the formalin test. ICV injection of insulin reduces pain sensation, but this was not observed in diabetic rats, which may be due to cell damage ameliorated by insulin.

Keywords: CNS; diabetes; gene; monoamine; pain.

MeSH terms

  • Analgesics / adverse effects
  • Animals
  • Diabetes Mellitus, Experimental* / metabolism
  • Insulin / pharmacology
  • Insulin Resistance*
  • Male
  • Pain / drug therapy
  • Rats
  • Reactive Oxygen Species / metabolism
  • Serotonin
  • Streptozocin

Substances

  • Insulin
  • Streptozocin
  • Reactive Oxygen Species
  • Serotonin
  • Analgesics